PIK3CD and Miyoshi myopathy: In the present study, we took advantage of the advancement of PI3K crystal structure, molecular docking, and combinatorial chemistry, and performed a high throughput virtual screen against 800,000 small molecule compounds using PI3Kγ as the subject and identified a promising PI3K inhibitor with a novel scaffold for MM treatment.